1 – 10 of 69
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Chemotherapy, host response and molecular dynamics in periampullary cancer : The CHAMP study
- 2019
-
Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition
Berntsson, Jonna LU
;
Eberhard, Jakob
LU
;
Nodin, Björn
LU
;
Leandersson, Karin
LU
;
Larsson, Anna H
LU
and
Jirström, Karin
LU
(2019)
In OncoImmunology
8(12).
Mark
- Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
- Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment
-
Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome
Lundgren, Sebastian LU ; Olsson Hau, Sofie LU ; Elebro, Jacob LU ; Heby, Margareta LU ; Karnevi, Emelie LU ; Nodin, Björn LU ; Eberhard, Jakob LU ; Holm, Karolina LU ; Staaf, Johan LU
and
Jönsson, Göran B
LU
, et al.
(2019)
In JCO Precision Oncology
3.
p.1-8
Mark
- 2018
- Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification
- High risk of hypogonadism in young male cancer survivors
- Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment
- Significance of poor performance status after resection of colorectal liver metastases
-
Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer : Relationship with sidedness and prognosis
Berntsson, Jonna LU
;
Eberhard, Jakob
LU
;
Nodin, Björn
LU
;
Leandersson, Karin
LU
;
Larsson, Anna H.
LU
and
Jirström, Karin
LU
(2018)
In OncoImmunology
7(8).
Mark